Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial

R. A. Nout, V. T. H. B. M. Smit, H. Putter, Ina M. Juergenliemk-Schulz, Jan J. Jobsen, L. C. H. W. Lutgens, Elzbieta M. van der Steen-Banasik, Jan Willem M. Mens, A. Slot, Marika C. Stenfert Kroese, B. N. F. M. van Bunningen, A. C. Ansink, W. L. J. van Putten, C. L. Creutzberg

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)816-823
JournalLancet
Volume375
Issue number9717
DOIs
Publication statusPublished - 6 Mar 2010

Cite this

Nout, R. A., Smit, V. T. H. B. M., Putter, H., Juergenliemk-Schulz, I. M., Jobsen, J. J., Lutgens, L. C. H. W., van der Steen-Banasik, E. M., Mens, J. W. M., Slot, A., Kroese, M. C. S., van Bunningen, B. N. F. M., Ansink, A. C., van Putten, W. L. J., & Creutzberg, C. L. (2010). Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet, 375(9717), 816-823. https://doi.org/10.1016/S0140-6736(09)62163-2